Follow
Galeazzi Mauro
Galeazzi Mauro
Professore Ordinario di Reumatologia, Università di Siena
Verified email at unisi.it
Title
Cited by
Cited by
Year
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2002
25492002
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ...
Medicine 82 (5), 299-308, 2003
17622003
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD SEBASTIANI, A Gil, P Lavilla, ...
Medicine 72 (2), 113-124, 1993
13371993
Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ...
Arthritis & Rheumatism 46 (8), 2121-2131, 2002
12942002
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ...
Annals of the rheumatic diseases 74 (6), 1011-1018, 2015
1088*2015
Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients
R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ...
Medicine 78 (3), 167-175, 1999
5931999
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ...
Annals of the rheumatic diseases 69 (01), 61-64, 2010
5892010
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ...
Arthritis & rheumatism 50 (12), 3934-3940, 2004
4652004
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there?
A Fioravanti, L Cantarini, GM Guidelli, M Galeazzi
Rheumatology international 31, 1-8, 2011
3032011
miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis
V Fulci, G Scappucci, GD Sebastiani, C Giannitti, D Franceschini, ...
Human immunology 71 (2), 206-211, 2010
2942010
Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta‐analysis
FB Karassa, A Afeltra, A Ambrozic, DM Chang, F De Keyser, A Doria, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2006
2492006
Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled …
A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ...
Arthritis & rheumatology 71 (4), 599-611, 2019
2292019
Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative
AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ...
Ophthalmology 125 (5), 757-773, 2018
2262018
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes
A Spreafico, F Chellini, B Frediani, G Bernardini, S Niccolini, T Serchi, ...
Journal of Cellular Biochemistry 108 (5), 1153-1165, 2009
1972009
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the …
F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ...
Autoimmunity reviews 12 (2), 225-229, 2012
1962012
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed
B Frediani, G Filippou, P Falsetti, S Lorenzini, F Baldi, C Acciai, C Siagkri, ...
Annals of the rheumatic diseases 64 (4), 638-640, 2005
1882005
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the “Euro-Lupus Project”
R Cervera
Autoimmunity reviews 5 (3), 180-186, 2006
1872006
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
L Mancarella, F Bobbio-Pallavicini, F Ceccarelli, PC Falappone, ...
The Journal of rheumatology 34 (8), 1670-1673, 2007
1812007
HCV infection: pathogenesis, clinical manifestations and therapy
A Antonelli, C Ferri, M Galeazzi, C Giannitti, D Manno, G Mieli-Vergani, ...
Clinical and Experimental rheumatology 26 (2), S39, 2008
1722008
Hyperhomocysteinemia, inflammation and autoimmunity
PE Lazzerini, PL Capecchi, E Selvi, S Lorenzini, S Bisogno, M Galeazzi, ...
Autoimmunity reviews 6 (7), 503-509, 2007
1612007
The system can't perform the operation now. Try again later.
Articles 1–20